The biotech industry in 2024 presents a stark contrast. On one hand, a surge of startups is enjoying robust financial support and offering abundant job opportunities. On the other hand, major established companies are grappling with significant layoffs and restructuring efforts. This juxtaposition
Sutro Biopharma Inc. (NASDAQ:STRO) has been experiencing a challenging period, marked by considerable stock price fluctuations and substantial revenue declines. This California-based biotech firm, specializing in oncology therapeutics, is grappling with mixed sentiments among investors amidst a
The FDA's Center for Drug Evaluation and Research (CDER) has embarked on a robust modernization initiative to transform its New Drug Regulatory Program (NDRP). Launched in 2017, this comprehensive effort aims to enhance the efficiency and effectiveness of CDER processes in response to
The FDA's New Drug Regulatory Program (NDRP) within the Center for Drug Evaluation and Research (CDER) has undergone substantial modernization efforts since its launch in 2017. Aimed at enhancing the efficiency and effectiveness of CDER processes in light of advances in genetic science,
In a significant move within the pharmaceutical manufacturing industry, Veranova has announced a substantial $30 million investment to enhance its Devens, Massachusetts facility. This strategic expansion is designed to bolster Veranova’s capabilities in developing and manufacturing antibody-drug c
In a significant move to improve data practices within the biopharmaceutical industry, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has partnered with the Open Applications Group (OAGi). This collaboration aims to overcome the prevalent issue of data